Articles

Therapeutic Goods Administration

The Australian community's access to authoritative information about the safety of medicines and medical devices will be greatly enhanced with the launch today of a revamped Therapeutic Goods Administration (TGA) website.

On 4 May 2011 the TGA is going to launch its new corporate website.

Australia's medicines regulator, the Therapeutic Goods Administration, has today issued precautionary advice to doctors not to give patients a second dose of the vaccine Pneumovax 23 pending completion of an investigation into an increased rate of adverse events in people receiving the vaccine for the second time.

TGA is conducting a panel-led review to explore ways to improve transparency and public engagement in its regulatory work.

Therapeutic Goods Order No. 1 of 2010.

The Therapeutic Goods Administration (TGA) officially launched a new organisational structure on 1 July 2010.

The Therapeutic Goods Administration (TGA) has approved an extension to the shelf life for Tamiflu (oseltamivir) from five to seven years, when stored below 25°C. This extension is effective from 1 May 2009.

This Order may be cited as the Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2004.

Listing notice - fungal enzymes

Listing notice - curcumin

Listing notice - iron phosphate

Listing notice - Terminalia ferdinandiana (Kakadu plum)

Listing notice - sodium sulfate

Listing notice - cold-pressed neem (Azadirachta indica) seed oil

Listing notice - Trametes versicolor hyphae aqueous extract - powder

Listing notice - boric acid, borax, sodium perborate, borax pentahydrate, molybdenum trioxide, magnesium phosphate dibasic trihydrate

Listing notice - emu oil

Listing notice - zeaxanthin

Listing notice - lutein

Listing notice - activated charcoal

Listing notice - bovine colostrum powder

Listing notice - bovine colostrum powder

Listing notice - demineralised fish proteoglycan extract

Listing notice - black boned chicken powder, conifer phytosterol complex